Gu, Jie <br/><br/>
The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma.  [electronic resource] 

 -  Molecular pharmaceutics  11 2018 
 - 5387-5396 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/acs.molpharmaceut.8b00880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--pharmacokinetics<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line, Tumor<br/>Drug Synergism<br/>Heterocyclic Compounds, 3-Ring--pharmacokinetics<br/>Humans<br/>Mice<br/>Multiple Myeloma--drug therapy<br/>Prospective Studies<br/>Proteins--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays